Key takeaways:
Wegovy is a glucagon-like peptide-1 (GLP-1) medication that can cause an average weight loss of 15% of your total body weight.
The effects of Wegovy aren’t immediate after you take the first dose, but you may notice some medication effects within the first couple of weeks. For those who respond to the medication, you may see 5% weight loss within 3 months of starting Wegovy.
You’re more likely to see gradual weight loss after the first month’s starter dose. More significant weight loss usually follows as your dose increases to the maintenance dose.
Save on related medications
Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist medication that’s commonly used for weight loss. On average, people taking Wegovy during clinical trials were able to lose up to 15% of their body weight.
If you’re just starting your weight-loss journey with Wegovy, you may be wondering what to expect and how soon you’ll see results. Most people can expect to feel the effects of the medication within the first couple of weeks. But it’s important to keep in mind that everyone’s weight-loss results will vary while taking Wegovy.
Let’s take a closer look at what the research shows on how long Wegovy takes to work and what you can expect while you’re taking it.
How long does it take for Wegovy to work?
Wegovy doesn’t work immediately after your first dose. The starting dose of GLP-1s is typically a low dose to get your body adjusted to the medication. It’s then increased every 4 weeks to get you to an effective dose where you see significant weight loss.
But many people begin to notice better appetite control and less hunger in the first few weeks of starting Wegovy. After the first month on Wegovy, you should start to see weight loss as your dose is increased. Some people may notice about 5% weight loss within 3 months and about 10% weight loss within 6 months of starting Wegovy.
This is just an average timeline. Each person will respond differently to Wegovy, so there’s not a specific timeframe to expect to see weight loss. It’s important to take the medication exactly as prescribed, though, for the best results.
How can you tell if Wegovy is working?
It can take some time after starting Wegovy before you see results. You may have some clues that Wegovy is working if you notice:
The scale showing weight loss
Your clothes fitting loosely
Less food noise
Less hunger
Feeling more satisfied
Your prescriber will continue to adjust your dose every 4 weeks as needed, until you reach your maintenance dose. Most people can expect a steady rate of weight loss when they reach their maintenance dose and are taking it as directed.
What can you expect after your first dose of Wegovy?
You’re not likely to notice any immediate effects after your very first dose of Wegovy. Within weeks, you’ll start to notice the medication working to curb your appetite and help you feel more full. Realistically, though, it may take several doses before you notice any significant changes or weight loss from Wegovy.
How does Wegovy work?
Wegovy and other GLP-1s mimic a natural hormone produced by your body called glucagon-like peptide-1. GLP-1 medications have several positive effects in the body that help with metabolism, weight loss, and overall health. Wegovy helps to cause weight loss by:
Slowed stomach emptying, which allows you to feel full
Direct impact on the brain to decrease cravings and help you feel more satisfied
Regulating appetite hormones
Wegovy also works to improve the overall metabolic health and decreases inflammation throughout the body. This helps to decrease the risk of two health conditions:
Heart and blood vessel disease
Metabolic dysfunction-associated steatohepatitis (MASH), previously known as fatty liver disease
The FDA has approved the use of Wegovy for both of these conditions.
What should you do if you aren’t losing weight with Wegovy?
Not everyone will see the weight loss they expected while taking Wegovy, and each person’s results will vary. If you aren’t losing as much weight as you’d hoped, check out these tips for common pitfalls while taking GLP-1s:
Make sure you’re taking all the doses as prescribed.
If you aren’t at the maximum dose, talk to your prescriber about increasing the dose.
Make sure you’re getting enough physical activity.
Talk with a healthcare professional about improving your diet and nutrition.
Talk to your prescriber about your medical history and any other medications you’re taking to see if they might be interfering with weight loss.
Consider trying a different GLP-1 medication or form (oral versus injection).
Try to get plenty of sleep and control your stress levels.
About 10% to 15% of people are considered non-responders to Wegovy. You may be a non-responder if you haven’t lost at least 5% of your body weight by your sixth month of treatment. But the good news is that even non-responders can have significant weight loss within a year’s time if they continue the medication.
How can you maximize weight loss with Wegovy?
Wegovy is designed for use along with lifestyle changes like increased activity and a reduced-calorie eating plan that’ll help support weight loss. You can maximize your weight loss with Wegovy by following these tips:
Take the medication exactly as prescribed.
Eat a nutritious, reduced-calorie diet.
Make time to move your body on a regular basis.
Talk to your prescriber about increasing your dose (if you’re not on the maximum dose).
Manage your stress and improve your sleep.
Keep in mind: Wegovy is very effective, but it works best when you’re consistent with your dosing schedule, eating plan, and activity.
Frequently asked questions
In general, most people see only modest weight loss, if any, in the first month of taking Wegovy. That’s because you’ll start on the lowest Wegovy dose for the first 4 weeks. Weight loss tends to pick up after you’ve been on higher doses of the medication for some time. But keep in mind that the rate at which you lose weight while taking Wegovy varies from person to person.
Oral and injectable Wegovy have the same effectiveness when it comes to weight loss, heart-health outcomes, and quality of life. Ultimately, the medication form that works best for you is the one that fits your lifestyle and that you’re more likely to take consistently. A healthcare professional can help you decide which form is best for you.
Most people stay on Wegovy long term to maintain their results. People who stop taking glucagon-like peptide-1 (GLP-1) medications tend to regain much of their weight and reverse the health benefits from taking them.
A typical Wegovy dosage depends on if you’re taking the injection or Wegovy pill. The starting dose of the Wegovy injection is 0.25 mg once a week. The dosage is increased every 4 weeks — up to a maintenance dose of either 1.7 mg or 2.4 mg per week. Wegovy HD is a high-dose injection at 7.2 mg per week.
The starting dose for the Wegovy pill is 1.5 mg daily. This dosage is increased every 30 days — up to a maximum of 25 mg daily.
Some of the most common side effects of Wegovy include:
Nausea
Vomiting
Diarrhea
Stomach pain
Keep in mind that side effects are possible with any medication. In order to reduce the risk of side effects, make sure to increase the dosage slowly over time.
In general, most people see only modest weight loss, if any, in the first month of taking Wegovy. That’s because you’ll start on the lowest Wegovy dose for the first 4 weeks. Weight loss tends to pick up after you’ve been on higher doses of the medication for some time. But keep in mind that the rate at which you lose weight while taking Wegovy varies from person to person.
Oral and injectable Wegovy have the same effectiveness when it comes to weight loss, heart-health outcomes, and quality of life. Ultimately, the medication form that works best for you is the one that fits your lifestyle and that you’re more likely to take consistently. A healthcare professional can help you decide which form is best for you.
Most people stay on Wegovy long term to maintain their results. People who stop taking glucagon-like peptide-1 (GLP-1) medications tend to regain much of their weight and reverse the health benefits from taking them.
A typical Wegovy dosage depends on if you’re taking the injection or Wegovy pill. The starting dose of the Wegovy injection is 0.25 mg once a week. The dosage is increased every 4 weeks — up to a maintenance dose of either 1.7 mg or 2.4 mg per week. Wegovy HD is a high-dose injection at 7.2 mg per week.
The starting dose for the Wegovy pill is 1.5 mg daily. This dosage is increased every 30 days — up to a maximum of 25 mg daily.
Some of the most common side effects of Wegovy include:
Nausea
Vomiting
Diarrhea
Stomach pain
Keep in mind that side effects are possible with any medication. In order to reduce the risk of side effects, make sure to increase the dosage slowly over time.
The bottom line
Wegovy is an effective weight-loss treatment, with many people in clinical trials losing up to 15% of their body weight. For most people, weight loss is typically gradual in the beginning — especially while you’re on the starting dose. Your prescriber will increase your dosage every 4 weeks after that, and that’s when significant weight loss tends to happen. Keep in mind that the results take time and will vary from person to person. A healthcare professional can help guide you on what type of weight loss results you should expect with Wegovy.
Why trust our experts?
References
Ghusn, W., et al. (2022). Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity. JAMA Network Open.
Mosenzon, O., et al. (2021). Clinically-relevant weight loss is achieved independently of early weight loss response to once-weekly subcutaneous semaglutide 2.4 mg (STEP 4). Journal of the Endocrine Society.
Novo Nordisk Inc. (2026). Wegovy [package insert].
Pinto, M., et al. (2025). Real-world comparison of oral versus injectable semaglutide for the reduction of hemoglobin A1C and weight in patients with type 2 diabetes. The Journal of Pharmacy Technology.
PR Newswire. (2025). Novo Nordisk presents four new analyses on oral semaglutide 25 mg (Wegovy® in a pill*) at ObesityWeek® 2025, including demonstrated reductions in cardiovascular risk factors.
Rosen, C. J., et al. (2026). GLP-1 receptor agonists. The New England Journal of Medicine.
Wilding, J. P. H., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. The New England Journal of Medicine.
